THE GENERIC INDUSTRY OFFERS PHENOMENAL OPPORTUNITIES, AND A SUBSTANTIAL RISK
Built on more than a decade’s experience supplying solutions to meet critical business challenges in the highly competitive and global generic and API markets, Newport products are now used by more than 250 companies operating in 50 countries around the world.
If you are a generic company, we can help you target products for development, locate qualified sources of API, monitor your competition, and find partners. Click to learn more
If you are an API manufacturer, we can help you target products for development, uncover buyers for your active ingredients, monitor your competition, and find partners. Click to learn more
- Please click here to update us regarding your product line and manufacturing capabilities
If you are an innovator, we can help you monitor your competition, find licensing partners, and locate sources of API. Click to learn more
If you are specialty company, we can help you target products for development, locate qualified sources of API, monitor your competition, and find partners and licensing opportunities. Click to learn more
If you are a PBM, health insurer, or retail pharmacy, we can help you manage your costs by enabling you to identify likely suppliers and their relative negotiating strengths, intensity of competition, and timing of generic entry. Click to learn more
If you are a financial company, we can help you monitor generic competition for key products and companies. Click to learn more
Our solutions for Generics, API Manufacturers, PBMs, Pharmacies, and Analysts
- Newport for Generics - Premium, Global, and Sourcing packages: The critical product targeting, global business development and API sourcing system from Thomson Reuters, the industry authority on the global generics market.
- Newport Phase III Drugs Module - Intelligence on products still in phase III clinical trials or going through registrations.
- Newport Generic Deals Module - Many thousands of merger, acquisition, development, supply, manufacturing, joint venture, patent settlement and authorized generic deals involving generic companies worldwide since 1999.
Our solutions for Innovators
- Newport for Innovators - Premium, Global, and Sourcing packages: The most advanced competitive intelligence, business development and global active pharmaceutical ingredient (API) sourcing system from Thomson Reuters, the industry authority on the global generics market.
- Newport Generic Deals Module - Many thousands of merger, acquisition, development, supply, manufacturing, joint venture, patent settlement and authorized generic deals involving generic companies worldwide since 1999.
Check back soon for upcoming events
In the meantime, check out our Life Sciences Expert Directory
In this white paper, Thomson Reuters draws on the unique intelligence of Newport PremiumTM and Thomson Pharma® to reveal exactly what’s happening in the Japanese generic drug market, and predicts how the situation may change under the incoming Democratic Party of Japan (DPJ) administration. Receive your copy today
Our overview of the most significant game-play in the US generics market.
- Stay ahead of the latest trends and find out who’s doing what - with the Pharma Knowledge Hub .
- Industry Information: Download glossary of industry terms PDF
- System Support
Essential Solutions
Who can benefit
- Generic drugs companies
- Competitive intelligence professionals
- Intellectual property professionals
- Licensing and business development
- API manufacturers
- Regulatory affairs managers
- Brand managers/marketing